2-18F-fluoropropionic acid as a PET imaging agent for prostate cancer

Journal of Nuclear Medicine

Volumn 50, Issue 10, 2009, Pages 1709-1714

  Pillarsetty, NagaVaraKishore ^a,b   Punzalan, Blesida ^a   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE   (United States)

Author keywords

2 18F fluoropropionic acid; 11C acetate; CWR22rv1; PET; Prostate cancer

Indexed keywords

2 FLUOROPROPIONIC ACID F 18; ACETIC ACID C 14; ANDROGEN; FLUORODEOXYGLUCOSE F 18; TRACER; UNCLASSIFIED DRUG; 2 18F FLUOROPROPIONIC ACID; 2-18F-FLUOROPROPIONIC ACID; ACETIC ACID DERIVATIVE; CARBON; DIAGNOSTIC AGENT; FLUOROCARBON; OCTANOL; PROPIONIC ACID; PROPIONIC ACID DERIVATIVE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TUMOR LEVEL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; QUANTUM YIELD; RADIOCHEMISTRY; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; METHODOLOGY; PROSTATE TUMOR; SCINTISCANNING; TISSUE DISTRIBUTION;

ACETATES; ANIMALS; CARBON RADIOISOTOPES; FLUOROCARBONS; MALE; MICE; OCTANOLS; POSITRON-EMISSION TOMOGRAPHY; PROPIONIC ACIDS; PROSTATIC NEOPLASMS; RADIOACTIVE TRACERS; TISSUE DISTRIBUTION; WATER;

EID: 70349640056     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.064212     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. John SS, Zietman AL, Shipley WU, Harisinghani MG. Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases. Int J Radiat Oncol Biol Phys. 2008;71(1, suppl)S43-S47.
3. Bouchelouche K, Oehr P. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol. 2008;179:34-45. (Pubitemid 350225698)
4. 18F-fluoroacetate using PET/CT. Eur J Nucl Med Mol Imaging. 2004;31:797.
5. 11C-acetate. J Nucl Med. 2007;48:420-428.
6. 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61:110-117.
7. 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35:976-983.
8. Vees H, Buchegger F, Albrecht S, et al. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy. BJU Int. 2007;99:1415-1420. (Pubitemid 47164795)
9. Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 2007;37:420-428. (Pubitemid 47498259)
10. Veach DR, Namavari M, Pillarsetty N, et al. Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib. J Med Chem. 2007;50:5853-5857. (Pubitemid 350106039)
11. 18F] labeled pyrimidine nucleosides for positron emission tomography imaging of herpes simplex virus 1 thymidine kinase gene expression. J Med Chem. 2006;49:5377-5381.
12. 124I-labeled small molecular tracer and positron emission tomography. Mol Imaging Biol. 2006;8:262-277.
13. 131I]-2- (4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors. Nucl Med Biol. 2005;32:313-321.
14. Lorber SH, Komarov SA, Shay H. Effect of sham feeding on gastric motor activity of the dog. Am J Physiol. 1950;162:447-451.
15. Pritchard GI, Tove SB. Interrelationships between the metabolism of short-chain fatty acids by ruminant liver slices. Biochim Biophys Acta. 1960;41:130-137.
16. Guhlke S, Coenen HH, Stocklin G. Fluoroacylation agents based on small Nca [F-18] fluorocarboxylic acids. Appl Radiat Isot. 1994;45:715-727. (Pubitemid 24190145)
17. Chan SY, Brunken RC, Phelps ME, Schelbert HR. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. J Nucl Med. 1991;32:665-672.
18. Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med. 1991;32:245-251.
19. 11C-acetate. J Nucl Med. 2003;44:556-558.
20. 11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008;49:327-334.
21. Knust EJ, Kupfernagel C, Stocklin G. Long-chain F-18 fatty acids for the study of regional metabolism in heart and liver: odd-even effects of metabolism in mice. J Nucl Med. 1979;20:1170-1175. (Pubitemid 10209201)
22. 18F-galacto- RGD, a new radiotracer for imaging alpha v beta3 expression. J Nucl Med. 2006;47:763-769.
23. Lock EA, Gyte A, Sturgess NC, Duffell S, Wyatt I. 2-Halopropionic acid-induced cerebellar granule cell necrosis in the rat: in vivo and in vitro studies. Neurotoxicology. 2001;22:363-374. (Pubitemid 32612378)
24. Buchanan JM, Hastings AB, Nesbett FB. The role of carboxyl-labeled acetic, propionic and butyric acids in liver glycogen formation. J Biol Chem. 1943;150:413-425.